WO2019203771A3 - Solid oral pharmaceutical compositions comprising sitagliptin - Google Patents

Solid oral pharmaceutical compositions comprising sitagliptin Download PDF

Info

Publication number
WO2019203771A3
WO2019203771A3 PCT/TR2019/050139 TR2019050139W WO2019203771A3 WO 2019203771 A3 WO2019203771 A3 WO 2019203771A3 TR 2019050139 W TR2019050139 W TR 2019050139W WO 2019203771 A3 WO2019203771 A3 WO 2019203771A3
Authority
WO
WIPO (PCT)
Prior art keywords
sitagliptin
pharmaceutical compositions
solid oral
oral pharmaceutical
pharmaceutically acceptable
Prior art date
Application number
PCT/TR2019/050139
Other languages
French (fr)
Other versions
WO2019203771A2 (en
Inventor
Ali Turkyilmaz
Seval Ataman
Cagil ERKAY
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to EP19788122.0A priority Critical patent/EP3781135A4/en
Publication of WO2019203771A2 publication Critical patent/WO2019203771A2/en
Publication of WO2019203771A3 publication Critical patent/WO2019203771A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to solid oral pharmaceutical compositions comprising sitagliptin and a pharmaceutically acceptable excipient thereof, providing high stability and improved dissolution profile.
PCT/TR2019/050139 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin WO2019203771A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19788122.0A EP3781135A4 (en) 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201805447 2018-04-17
TR2018/05447 2018-04-17

Publications (2)

Publication Number Publication Date
WO2019203771A2 WO2019203771A2 (en) 2019-10-24
WO2019203771A3 true WO2019203771A3 (en) 2020-01-16

Family

ID=68240633

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050139 WO2019203771A2 (en) 2018-04-17 2019-03-06 Solid oral pharmaceutical compositions comprising sitagliptin

Country Status (2)

Country Link
EP (1) EP3781135A4 (en)
WO (1) WO2019203771A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020018034A2 (en) * 2018-04-17 2020-01-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Oral pharmaceutical compositions comprising dpp-4 inhibitor
CN114828831A (en) * 2019-12-24 2022-07-29 韩美药品株式会社 Compound preparation containing sitagliptin and dapagliflozin and preparation method thereof
CN111481520A (en) * 2020-06-15 2020-08-04 千辉药业（安徽）有限责任公司 Sitagliptin phosphate tablet
CN114159401A (en) * 2021-11-18 2022-03-11 苏州天马医药集团天吉生物制药有限公司 Sitagliptin phosphate tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014057059A1 (en) * 2012-10-11 2014-04-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Effervescent cefdinir formulation
WO2014174469A1 (en) * 2013-04-25 2014-10-30 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising a combination of sitagliptin and metformin
EP2853257A1 (en) * 2013-09-12 2015-04-01 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of linagliptin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120258170A1 (en) * 2009-05-20 2012-10-11 Nutracryst Therapeutics Private Limited Pharmaceutical co-crystals of quercetin
EP2295083A1 (en) 2009-09-15 2011-03-16 Ratiopharm GmbH Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014057059A1 (en) * 2012-10-11 2014-04-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Effervescent cefdinir formulation
WO2014174469A1 (en) * 2013-04-25 2014-10-30 Ranbaxy Laboratories Limited Pharmaceutical compositions comprising a combination of sitagliptin and metformin
EP2853257A1 (en) * 2013-09-12 2015-04-01 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of linagliptin

Also Published As

Publication number Publication date
EP3781135A2 (en) 2021-02-24
WO2019203771A2 (en) 2019-10-24
EP3781135A4 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
WO2019203771A3 (en) Solid oral pharmaceutical compositions comprising sitagliptin
EP4233846A3 (en) Pharmaceutical formulations
EP3743092A4 (en) Peptide yy pharmaceutical formulations, compositions, and methods
WO2018165404A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
EP4045480A4 (en) Pharmaceutical formulations
MX2020009857A (en) Il-2 conjugates.
WO2019194773A3 (en) The combination comprising linagliptin and metformin
MX2017016802A (en) Pharmaceutical formulations.
EP4041734A4 (en) Novel derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
EA201991287A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE
WO2019240699A3 (en) Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion
EP3539978A4 (en) Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
MX2021010022A (en) Pharmaceutical composition.
MX2024009106A (en) Pharmaceutical composition containing acetominophen and ibuprofen.
EP4034120A4 (en) Solid oral pharmaceutical formulations comprising sapropterin dihydrochloride and at least one pharmaceutical excipient
MX2019001771A (en) Solid pharmaceutical composition comprising amorphous sofosbuvir.
EP4015001A4 (en) Oral pharmaceutical composition
MX2021014830A (en) CONJUGATES OF <i>π</i>-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS.
WO2017064652A3 (en) Low dose oral dipyridamole compositions and uses thereof
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
WO2019098572A3 (en) Pharmaceutical composition for alleviating liver fibrosis induced by hepatitis virus
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
EP4065598A4 (en) Biotin moiety-conjugated polypeptide and pharmaceutical composition for oral administration comprising the same

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019788122

Country of ref document: EP

Effective date: 20201117

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19788122

Country of ref document: EP

Kind code of ref document: A2